Zachary B. Fleming - 07 Mar 2024 Form 4 Insider Report for Sanara MedTech Inc. (SMTI)

Reporting relationship: Chief Executive Officer
Issuer ticker: SMTI
Reported as of: 07 Mar 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Mar 2024, 16:05:37 UTC
Prior SEC filing: 05 Mar 2024
Source filing: View source filing
Reporting owner signature: /s/ Zachary B. Fleming

Key filing fact

Zachary B. Fleming filed Form 4 for Sanara MedTech Inc. (SMTI) on 11 Mar 2024.

Key facts

This page summarizes Zachary B. Fleming's Form 4 filing for Sanara MedTech Inc. (SMTI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Mar 2024, 16:05.

Change

Previous filing in this sequence was filed on 05 Mar 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SMTI transaction

Common Stock

Award

Transaction value: $0
Shares: +12,693
Change %: +35%
Price: $0.000000
Shares after: 48,854
Date: 07 Mar 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 7, 2025, 2026 and 2027, respectively.